{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:51:29Z","timestamp":1788187889401,"version":"build-2803163510"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Modern Rheumatology"],"published-print":{"date-parts":[[2020,1,2]]},"DOI":"10.1080\/14397595.2018.1538004","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T13:29:11Z","timestamp":1539869351000},"page":"132-140","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy and safety of secukinumab in Japanese patients with active ankylosing spondylitis: 24-week results from an open-label phase 3 study (MEASURE 2-J)"],"prefix":"10.1093","volume":"30","author":[{"given":"Mitsumasa","family":"Kishimoto","sequence":"first","affiliation":[{"name":"Immuno-Rheumatology Center, St. Luke\u2019s International University and St Luke\u2019s International Hospital, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Institute of Rheumatology, Tokyo Women\u2019s Medical University, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Fujishige","sequence":"additional","affiliation":[{"name":"Novartis Pharma K.K., Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Novartis Pharma K.K., Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Haemmerle","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian O.","family":"Porter","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, East Hanover, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Juntendo Koshigaya Hospital, Juntendo University, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2012.692341"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.2014.957679"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2014.10.007"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-013-0344-0"},{"issue":"3","key":"CIT0006","first-page":"554","volume":"28","author":"Hukuda S","year":"2001","journal-title":"J Rheumatol"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oso\/9780192627490.003.0002","volume-title":"The Spondylarthritides","author":"Khan AK","year":"1998"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2012.09.003"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.3329\/bmrcb.v40i3.25231"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151027"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker194"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-011-0557-x"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2016.1176635"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-013-0356-9"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087270"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.53"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Braun J, Baraliakos X, Deodhar AA, Poddubnyy D, Emery P, Delicha EM, et al. Secukinumab demonstrates low radiographic progression and sustained efficacy through 4 years in patients with active ankylosing spondylitis [abstract]. Arthritis Rheumatol. 2017;69(suppl 10).","DOI":"10.1136\/annrheumdis-2018-eular.1396"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000592"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1490-y"},{"key":"CIT0020","unstructured":"Pavelka K, Kivitz AJ, Dokoupilova E, Blanco R, Maradiaga M, Tahir H, et al. Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis: 2-year results from a phase 3 study [abstract]. Arthritis Rheumatol. 2017;69(suppl 10)."},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.231"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1007\/BF03190261"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14965"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505066"},{"issue":"1","key":"CIT0025","first-page":"50","volume":"36","author":"Baraliakos X","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.064543"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209853"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780381120"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13094"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1372-3"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.876"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61134-5"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412679"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205253"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1093-z"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203582"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.09.003"},{"key":"CIT0038","doi-asserted-by":"crossref","unstructured":"Deodhar AA, Baraliakos X, Marzo-Ortega H, Sieper J, Andersson M, Porter B, et al. Secukinumab demonstrates consistent safety over long-term exposure (up to 3 years) in patients with active ankylosing spondylitis: pooled analysis of three phase 3 trials [abstract]. Arthritis Rheumatol. 2017;69(suppl 10).","DOI":"10.1136\/annrheumdis-2017-eular.4894"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/tandfonline.com\/doi\/pdf\/10.1080\/14397595.2018.1538004","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14397595.2018.1538004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T14:13:54Z","timestamp":1720707234000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/30\/1\/132-140\/6300342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,2]]}},"alternative-id":["10.1080\/14397595.2018.1538004"],"URL":"https:\/\/doi.org\/10.1080\/14397595.2018.1538004","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=imor20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=imor20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}